Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-158466
Filing Date
2023-06-01
Accepted
2023-06-01 08:22:57
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A d438169ddefa14a.htm DEFA14A 49718
2 GRAPHIC g438169g71p62.jpg GRAPHIC 8259
  Complete submission text file 0001193125-23-158466.txt   62321
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 000-50484 | Film No.: 23983068
SIC: 2834 Pharmaceutical Preparations